SubscribeIn the News

TRS: JOHNSON & JOHNSON PLANS TO DEVELOP A LINE OF 3-D PRINTED RECONSTRUCTIVE IMPLANTS

Thursday, June 26th, 2014 | Healthcare

MADISON VACCINES INCORPORATED ANNOUNCES EXPANSION OF A PHASE 2 CLINICAL TRIAL FOR MVI-816, ITS LEAD DNA VACCINE FOR PROSTATE CANCER

Monday, June 23rd, 2014 | Healthcare

TRS: JOHNSON & JOHNSON INNOVATION CATALYZES NEW AND EXCITING SCIENCE AND TECHNOLOGY IN PARMACEUTICAL, MEDICAL DEVICE, DIAGNOSTIC AND CONSUMER HEALTH SPACES

Thursday, June 19th, 2014 | Healthcare

ALFALIGHT RECEIVES $49M IDIQ CONTRACT FOR DELIVERY OF OCULAR INTERRUPTION LASER SYSTEM TO U.S. MARINE CORP

Tuesday, June 10th, 2014 | Technology

NEUMODX AND JEFF WILLIAMS CAPITALIZE ON LESSONS LEARNED AT HANDYLAB

Tuesday, June 10th, 2014 | Healthcare

NETSOCKET ROLLS OUT NEW SUITE OF VIRTUALIZED APPLICATIONS ENABLING MSPS TO GROW REVENUE AND DELIVER PROFITABLE NEW MANAGED SERVICES

Tuesday, June 3rd, 2014 | Technology

CELLECTAR BIOSCIENCES APPOINTS CHAD J. KOLEAN CHIEF FINANCIAL OFFICER

Thursday, May 29th, 2014 | Healthcare

ALFALIGHT RECEIVES $49M IDIQ CONTRACT FOR DELIVERY OF OCULAR INTERRUPTION LASER SYSTEM TO US MARINE CORPS

Thursday, May 29th, 2014 | Technology

LOCAL BIOTECH’S HEART FAILURE TREATMENT SHOWS PROMISE – JUVENTAS TO LAUNCH PHASE 3 STUDY NEXT YEAR

Wednesday, May 28th, 2014 | Healthcare

AKEBIA AIMS BIG WITH POTENTIAL DRUG FOR ANEMIA DUE TO CHRONIC KIDNEY DISEASE

Tuesday, May 27th, 2014 | Healthcare

HISTOSONICS NEARS CLOSE OF $14.2M FUNDING FOR NON-INVASIVE ABLATION

Tuesday, May 20th, 2014 | Healthcare

MADISON VACCINES ANNOUNCES THE APPOINTMENT OF MICHAEL RICHMAN TO ITS BOARD OF DIRECTORS

Wednesday, May 14th, 2014 | Healthcare

NEUWAVE MEDICAL, INC. NAMES DANIEL J. SULLIVAN AS PRESIDENT AND CEO

Monday, May 12th, 2014 | Healthcare

NEUROVANCE’S EB-1020 SR FOR ADULT ADHD SHOWS STIULANT-LIKE EFFICACY IN PHASE 2A TRIAL

Thursday, May 8th, 2014 | Healthcare

CELLECTAR BIOSCIENCES ANNOUNCES RECEIPT OF ORPHAN DESIGNATION OF I-124-CLR1404 AS DIAGNOSTIC FOR THE MANAGEMENT OF GLIOMA FROM U.S. FOOD AND DRUG ADMINISTRATION

Monday, May 5th, 2014 | Healthcare

AERPIO THERAPEUTICS PRESENTS FULL RESULTS FROM PHASE 1B/2A STUDY OF AKB-9778 FOR THE TREATMENT OF DIABETIC MACULAR EDEMA AT ARVO ANNUAL MEETING

Monday, May 5th, 2014 | Healthcare

AERPIO THERAPEUTICS CLOSES $22M FINANCING

Wednesday, April 23rd, 2014 | Healthcare

AKEBIA SOARS WITH ANALYSTS’ HIGH HOPES

Monday, April 14th, 2014 | Healthcare

NEUROVANCE CLOSES $6.3M FINANCING TO SUPPORT FURTHER DEVELOPMENT OF EB-1020 SR IN ADULT ADHD

Thursday, April 3rd, 2014 | Healthcare

CELLECTAR BIOSCIENCES NAMES NEW PRESIDENT, CEO

Wednesday, April 2nd, 2014 | Healthcare

RESHAPE DUO BALLOON OFFERS BARIATRIC SURGERY ALTERNATIVE

Tuesday, April 1st, 2014 | Healthcare

UPTO LAUNCHES A CALENDAR APP FOR THE FOMO GENERATION

Thursday, March 27th, 2014 | Technology

UPTO INTRODUCES THE CALENDAR OF THE FUTURE

Thursday, March 27th, 2014 | Technology

AKEBIA THERAPEUTICS ANNOUNCES CLOSING OF INITIAL PUBLIC OFFERING AND FULL EXERCISE OF UNDERWRITERS’ OPTION TO PURCHASE ADDITIONAL SHARES

Wednesday, March 26th, 2014 | Healthcare

MERCK LICENSES NANOBIO TECHNOLOGY

Wednesday, March 26th, 2014 | Healthcare

NEUMODX ANNOUNCES COMPLETION OF SERIES B FINANCING

Wednesday, March 26th, 2014 | Healthcare

CELLERATION REACHES KEY MILESTONE OF 1 MILLION MIST THERAPY TREATMENTS

Thursday, March 13th, 2014 | Healthcare

ANEMIA BIOTECH AKEBIA THERAPEUTICS SETS TERMS FOR $76 MILLION IPO

Friday, March 7th, 2014 | Healthcare

CHROMATIN, INC. ANNOUNCES FIVE NEW SORGHUM PRODUCTS

Thursday, February 27th, 2014 | Clean Tech

CHROMATIN, INC. ANNOUNCES PRODUCTION OF FARNESENE IN SORGHUM

Tuesday, February 25th, 2014 | Clean Tech

AKEBIA THERAPEUTICS FILES REGISTRATION STATEMENT FOR PROPOSED INITIAL PUBLIC OFFERING

Tuesday, February 18th, 2014 | Healthcare

AERPIO THERAPEUTICS INITIATES PHASE 2 STUDY OF TIE2 ACTIVATOR AKB-9778 FOR THE TREATMENT OF DIABETIC MACULAR EDEMA

Thursday, February 13th, 2014 | Healthcare

NETSOCKET INTRODUCES COMPLETELY VIRTUALIZED NETWORK SOLUTION OPTIMIZED FOR THE NETWORK EDGE

Tuesday, February 11th, 2014 | Technology

JUVENTAS THERAPEUTICS INITIATES PHASE II RETRO-HF CLINICAL TRIAL ENROLLMENT FOR PATIENTS WITH HEART FAILURE

Tuesday, February 4th, 2014 | Healthcare

SILATRONIX: NEW INVESTMENTS HAVE A MADISON BATTERY COMPANY ALL CHARGED UP

Sunday, February 2nd, 2014 | Clean Tech

CHROMATIN, INC. ANNOUNCES WINNERS IN NATIONAL SORGHUM PRODUCERS ANNUAL COMPETITION

Monday, January 27th, 2014 | Clean Tech

AKEBIA THERAPEUTICS STRENGTHENS ITS LEADERSHIP TEAM WITH KEY ADDITIONS

Monday, January 13th, 2014 | Healthcare

MADISON VACCINES CLOSES $8 MILLION SERIES A FINANCING

Monday, January 13th, 2014 | Healthcare

CHROMATIN, INC. CLOSES NEW FINANCING ROUND, ADDS PRIVATE EQUITY INVESTORS

Thursday, January 9th, 2014 | Clean Tech

NEUROVANCE SAYS INTERIM DATA FROM PHASE 2A PILOT STUDY OF EB-1020 SR SHOWS STIMULANT-LIKE EFFICACY, BUT WITH LOWER RISK OF ABUSE, FOR ADULT ADHD

Thursday, January 9th, 2014 | Healthcare

ALFALIGHT RECEIVES $1.7M CONTRACT FOR DELIVERY OF MARITIME DEFENSE LASER MODULES

Wednesday, January 8th, 2014 | Technology

HISTOSONICS: LOCAL COMPANY’S MEDICAL DEVICE GETS TRIAL TREATMENT USE AT U-M

Tuesday, December 24th, 2013 | Healthcare

VC IN 2014: VENTURE INVESTORS’ JOHN NEIS ON IMPROVING RETURNS IN LIFE SCIENCES

Thursday, December 19th, 2013 | Venture Investors

JUVENTAS THERAPEUTICS INITIATES FIRST CLINICAL TRIAL FOR RETROGRADE INFUSION OF A GENE THERAPY TO PATIENTS WITH HEART FAILURE

Monday, December 9th, 2013 | Healthcare

ICIS INNOVATION AWARD WINNERS, RENMATIX AND VIRENT, ANNOUNCE COLLABORATION ON BIO-BASED PACKAGING

Friday, December 6th, 2013 | Clean Tech

JIM ADOX AND VENTURE INVESTORS CHARGE FULL STEAM AHEAD

Tuesday, November 26th, 2013 | Venture Investors

ANN ARBOR’S HISTOSONICS NAMED INNOVATOR OF THE YEAR

Wednesday, November 13th, 2013 | Healthcare

MVCA CELEBRATES YEAR’S TOP DEALS, NAMES NEW BOARD CHAIR

Friday, November 8th, 2013 | Venture Investors

RESHAPE MEDICAL SUCCESSFULLY MEETS ENDPOINTS IN WEIGHT LOSS DEVICE PIVOTAL TRIAL

Thursday, November 7th, 2013 | Healthcare

AERPIO THERAPEUTICS ANNOUNCES SUCCESSFUL COMPLETION OF PHASE 1B/2A TRIAL IN DIABETIC MACULAR EDEMA AND $9 MILLION SERIES A EXTENSION

Wednesday, November 6th, 2013 | Healthcare

NANOBIO AWARDED UP TO $10 MILLION IN NIH FUNDING TO DEVELOP A PANDEMIC INFLUENZA VACCINE

Tuesday, October 29th, 2013 | Healthcare

JUVENTAS THERAPEUTICS COMPLETES ENROLLMENT OF PHASE II STOP-HF STUDY OF JVS-100 IN PATIENTS WITH SYMPTOMATIC HEART FAILURE

Monday, October 28th, 2013 | Healthcare

AKEBIA APPOINTS JASON A. AMELLO AS SENIOR VICE PRESIDENT, CHIEF FINANCIAL OFFICER AND TREASURER

Wednesday, October 16th, 2013 | Healthcare

NETSOCKET ANNOUNCES VIRTUALIZED NETWORKING SOLUTION OPTIMIZED FOR THE DISTRIBUTED ENTERPRISE

Wednesday, October 2nd, 2013 | Technology

NEUROVANCE ANNOUNCES FDA ACCEPTANCE OF IND APPLICATION FOR EB-1020 SR AND INITIATES PHASE 2A STUDY IN ADULT ADHD

Tuesday, September 24th, 2013 | Healthcare

NEW VENTURE INVESTORS FUND RAISES $80 MILLION

Saturday, September 14th, 2013 | Venture Investors

VIRENT DEVELOPING ENVIRONMENTALLY FRIENDLY BOTTLES FOR COKE

Saturday, September 14th, 2013 | Clean Tech

AKEBIA APPOINTS RENAL INDUSTRY VETERAN JOHN P. BUTLER AS PRESIDENT AND CEO

Wednesday, August 28th, 2013 | Healthcare

TISSUE REGENERATION SYSTEMS RECEIVES 510K APPROVAL

Monday, August 26th, 2013 | Healthcare

HISTOSONICS STARTS CLINICAL TRIAL FOR NON-INVASIVE PROSTATE TREATMENT

Thursday, August 8th, 2013 | Healthcare

AERPIO THERAPEUTICS REPORTS PUBLICATION OF DATA ON TIE2 ACTIVATOR, AKB-9778

Tuesday, August 6th, 2013 | Healthcare

AKEBIA THERAPEUTICS ANNOUNCES INITIATION OF PHASE 2B TRIAL OF ORAL ANEMIA CANDIDATE

Wednesday, July 24th, 2013 | Healthcare

DETROIT’S UPTO PIVOTS, COMPLETES A $2 MILLION SERIES A ROUND

Tuesday, July 23rd, 2013 | Technology

AKEBIA: OHIO 2Q VENTURE CAPITAL INVESTMENT NEARLY DOUBLES

Monday, July 22nd, 2013 | Healthcare

AKEBIA LEADS OHIO FUNDING IN SECOND QUARTER

Friday, July 19th, 2013 | Healthcare

NETSOCKET VIRTUALIZES END-TO-END SDN SOLUTION, OFFERS FREE DOWNLOAD OF PLATFORM

Thursday, July 18th, 2013 | Technology

NETSOCKET SHIFTS GEARS FROM MANAGING UNIFIED COMMUNICATIONS TO ENABLING SOFTWARE DEFINED NETWORKS

Thursday, July 11th, 2013 | Technology

UPTO 2.0 RE-INVENTS THE CALENDAR, THIS TIME TARGETING GOOGLE, OUTLOOK, AND APPLE

Thursday, July 11th, 2013 | Technology

NETSOCKET UNVEILS VIRTUALIZED SDN SOLUTION

Tuesday, July 9th, 2013 | Technology

VIRENT EARNS AWARD FOR NEXT GENERATION BIOFUEL CONVERSION

Monday, July 8th, 2013 | Clean Tech

PLANO-BASED NETSOCKET REVEALS WHAT IT DID WITH $9.2 MILLION IN VENTURE CAPITAL IT RAISED THIS YEAR

Monday, July 8th, 2013 | Technology

NETSOCKET UNVEILS INDUSTRY’S FIRST END-TO-END COMPLETELY VIRTUALIZED SDN SOLUTION

Monday, July 8th, 2013 | Technology

NETSOCKET TARGETS CISCO WITH SDN PITCH

Monday, July 8th, 2013 | Technology

NETSOCKET’S CLOUD EXPERIENCE MANAGER NOW WORKS WITH MICROSOFT LYNC SERVER

Tuesday, July 2nd, 2013 | Technology

WHAT’S ON TAP? UPTO CHECKS OFF MILESTONES OF GROWTH FOR ITS SOCIAL CALENDAR APP

Sunday, June 30th, 2013 | Technology